• 6537 Citations
  • 38 h-Index
19982021
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1998 2019

Filter
Review article
Review article
8 Citations (Scopus)

Administrative prescription review procedures and use of atypical antipsychotic medications in the department of veterans affairs

Rosenheck, R. & Leslie, D., Sep 1 2003, In : Mental Health Services Research. 5, 3, p. 149-153 5 p.

Research output: Contribution to journalReview article

Veterans
olanzapine
Antipsychotic Agents
Prescriptions
Psychiatry
20 Citations (Scopus)

Changing environments and alternative perspectives in evaluating the cost-effectiveness of new antipsychotic drugs

Rosenheck, R., Doyle, J., Leslie, D. & Fontana, A., Jan 1 2003, In : Schizophrenia Bulletin. 29, 1, p. 81-93 13 p.

Research output: Contribution to journalReview article

Clozapine
Antipsychotic Agents
Cost-Benefit Analysis
Costs and Cost Analysis
Haloperidol
12 Citations (Scopus)

Pharmacotherapy and health care costs among patients with schizophrenia and newly diagnosed diabetes

Leslie, D. & Rosenheck, R. A., Jul 1 2005, In : Psychiatric Services. 56, 7, p. 803-809 7 p.

Research output: Contribution to journalReview article

schizophrenia
Health Care Costs
chronic illness
Schizophrenia
health care
18 Citations (Scopus)

Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013

Burns, R. M., Pacula, R. L., Bauhoff, S., Gordon, A. J., Hendrikson, H., Leslie, D. & Stein, B. D., Jan 2 2016, In : Substance Abuse. 37, 1, p. 63-69 7 p.

Research output: Contribution to journalReview article

Opioid Analgesics
Medicaid
Buprenorphine
Methadone
Therapeutics
38 Citations (Scopus)

Second-generation antipsychotics: Cost-effectiveness, policy options, and political decision making

Rosenheck, R. A., Leslie, D. & Doshi, J. A., May 1 2008, In : Psychiatric Services. 59, 5, p. 515-520 6 p.

Research output: Contribution to journalReview article

Antipsychotic Agents
Cost-Benefit Analysis
Decision Making
Consumer Advocacy
Government Regulation
46 Citations (Scopus)

Where is Buprenorphine Dispensed to Treat Opioid Use Disorders? the Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties

Stein, B. D., Pacula, R. L., Gordon, A. J., Burns, R. M., Leslie, D., Sorbero, M. J., Bauhoff, S., Mandell, T. W. & Dick, A. W., Sep 1 2015, In : Milbank Quarterly. 93, 3, p. 561-583 23 p.

Research output: Contribution to journalReview article

Buprenorphine
Opioid Analgesics
Substance-Related Disorders
Physicians
Therapeutics